McIlrath & Eck LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 22.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177 shares of the healthcare conglomerate’s stock after selling 50 shares during the quarter. McIlrath & Eck LLC’s holdings in UnitedHealth Group were worth $89,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Center for Financial Planning Inc. raised its holdings in shares of UnitedHealth Group by 4.7% in the 4th quarter. Center for Financial Planning Inc. now owns 1,003 shares of the healthcare conglomerate’s stock worth $504,000 after purchasing an additional 45 shares in the last quarter. Wilbanks Smith & Thomas Asset Management LLC increased its position in shares of UnitedHealth Group by 1.3% in the fourth quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 28,618 shares of the healthcare conglomerate’s stock worth $14,370,000 after acquiring an additional 357 shares in the last quarter. Distillate Capital Partners LLC increased its position in shares of UnitedHealth Group by 48.8% in the fourth quarter. Distillate Capital Partners LLC now owns 33,921 shares of the healthcare conglomerate’s stock worth $17,033,000 after acquiring an additional 11,130 shares in the last quarter. SRS Capital Advisors Inc. increased its position in shares of UnitedHealth Group by 39.3% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,521 shares of the healthcare conglomerate’s stock worth $764,000 after acquiring an additional 429 shares in the last quarter. Finally, Nixon Peabody Trust Co. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $516,000. Institutional investors and hedge funds own 86.07% of the company’s stock.
In other UnitedHealth Group news, Director Paul R. Garcia bought 2,146 shares of UnitedHealth Group stock in a transaction dated Tuesday, February 22nd. The shares were bought at an average price of $464.97 per share, with a total value of $997,825.62. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 6,000 shares of the stock in a transaction that occurred on Friday, February 25th. The shares were sold at an average price of $470.38, for a total transaction of $2,822,280.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 18,000 shares of company stock valued at $8,776,840. Corporate insiders own 0.55% of the company’s stock.
NYSE:UNH traded down $15.87 during trading hours on Friday, hitting $508.55. 2,873,166 shares of the company traded hands, compared to its average volume of 2,999,332. The stock has a market capitalization of $477.50 billion, a price-to-earnings ratio of 27.84, a P/E/G ratio of 1.60 and a beta of 0.88. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The firm has a 50-day moving average of $507.83 and a 200 day moving average of $480.33. The company has a current ratio of 0.78, a quick ratio of 0.79 and a debt-to-equity ratio of 0.54.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $5.38 by $0.11. The firm had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period in the prior year, the company earned $5.31 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 22nd. Stockholders of record on Monday, March 14th were paid a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s dividend payout ratio is 31.75%.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.